The International Vaccine Institute (IVI) and Hilleman Laboratories have entered a strategic partnership to collaborate on the development of vaccines and biologics addressing global public health needs.

• Scope of Work: Covers research, clinical development, technology transfer, and manufacturing processes.
• Focus Areas: Targets infectious diseases and aims to improve access in low- and middle-income countries.
• Collaboration Model: Combines IVI’s clinical and public health capabilities with Hilleman’s expertise in product development and technology transfer.

This summary is based on a news article published by BioSpectrum Asia.

Image for illustrative purposes only. Source: Canva.